PtdIns-specific MPR pathway association of a novel WD40 repeat protein, WIPI49

Tim R Jeffries1, Stephen K Dove, Robert H Michell

  • 1Protein Phosphorylation Laboratory, Cancer Research UK London Research Institute, Lincoln's Inn Fields Laboratories, London WC2A 3PX, United Kingdom.

Insights

WIPI49, a novel WD40-repeat protein, binds phosphoinositides and regulates the endosomal and mannose-6-phosphate receptor (MPR) pathway. Its function depends on PI-binding, impacting endosomal organization and MPR distribution.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • WD40-repeat proteins are involved in diverse cellular functions.
  • Phosphoinositides are key signaling lipids regulating membrane trafficking.
  • The mannose-6-phosphate receptor (MPR) pathway is crucial for lysosomal enzyme sorting.

Purpose of the Study:

  • To characterize a novel WD40-repeat protein, WIPI49.
  • To investigate WIPI49's role in phosphoinositide binding and membrane trafficking.
  • To determine WIPI49's involvement in the MPR pathway.

Main Methods:

  • Immunofluorescent imaging to determine WIPI49 localization.
  • Live cell imaging to track WIPI49 trafficking.
  • Analysis of MPR pathway function in cells expressing wild-type or mutant WIPI49.
  • RNA interference (RNAi) to suppress WIPI49 expression.

Main Results:

  • WIPI49 binds 3-phosphorylated phosphoinositides.
  • WIPI49 localizes to trans-Golgi and endosomal membranes and traffics in a microtubule-dependent manner.
  • WIPI49 shares trafficking pathways with MPR and is enriched in clathrin-coated vesicles.
  • Ectopic expression of wild-type WIPI49 disrupts the MPR pathway, while a PI-binding mutant does not.
  • WIPI49 suppression affects endosomal organization and CI-MPR distribution.

Conclusions:

  • WIPI49 is a novel regulatory component of the endosomal and MPR pathway.
  • WIPI49's role is dependent on its phosphoinositide-binding properties mediated by its WD40 domain.
  • WIPI49 is essential for normal endosomal organization and CI-MPR trafficking.

Related Concept Videos

piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...